Homepage Slideshow
Prestigious $5 Million CIRM Scholar Research Training Award Received
September 24, 2021
Received a generous $5 million, 5-year grant from the California Institute for Regenerative Medicine (CIRM) that will allow its PhD students, postdoctoral fellows and clinical fellows to pursue careers in …
Early Use of Convalescent Plasma for COVID-19 Disease Progression
Use Does Not Prevent COVID-19 Disease Progression
Investigators at The Lundquist Institute and research colleagues at other institutions have found that passive immunization is not a viable strategy .
BioLabs LA at The Lundquist Institute Reaches 100% Capacity
The Institute's incubator now houses 30 start-ups
This critical milestone demonstrates the strong demand for entrepreneurial startup opportunities in the bioscience sphere in Los Angeles.
The Impact of COVID-19 on Children, Adolescents, and Family Wellness
Wednesday, June 30, 2021 at 5:30 PM Pacific
A Lundquist Institute Community Science Series Virtual Webinar
Lundquist Investigators Contribute to Global Genomic Research Study
Study Expands Genomic Research Into Diverse, Different Ancestries
Studies included data on Hispanics, African-Americans and East Asians.
Mystery Solved
Longstanding Fallopian Tube Transport Debate
A group of investigators led by The Lundquist Institute's Wei Yan, MD, PhD demonstrated that motile cilia in the Fallopian tube are essential for oocyte pickup.
Spearheading Life-Saving COVID-19 Research
Research Supports Core Mission to Save Lives and Empower Healthcare Equity
The Lundquist Institute has led or participated in eight COVID-19 clinical studies whose results have changed the world.
New Promising Compound for Male Contraceptive Pill
Non-hormonal compound purified from Chinese herb
Institute researchers discovered a natural compound that exhibits almost ideal male contraceptive effects in pre-clinical studies.